logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure HSR-4. Estimated number of clients receiving opioid substitution treatment each year in EU-15, 1993-2005


Estimated number of clients receiving treatment each year as shown in the graphic is different from the number entering treatment each year.

Information has been updated from 2006 bulletin wherever available.

In some years, data were combined because of missing information from two years’ data, but on average represent clients for only one year.


Datasets for 1997-1998 and 2001-2002 were published in the 2003 EMCDDA Annual Report, Table 3. See - http://ar2003.emcdda.europa.eu/en/page104-en.html.

See also 'General notes for interpreting data' on the Explanatory notes and help page.


Estimates for 1993 and 1995 derived from: Farrell, M., Verster, A., Davoli, M., et al. (2000) Reviewing Current Practice in Drug-substitution Treatment in the European Union. EMCDDA Insights No 3, Lisbon, p 22. Farrell, M., Neeleman, J., Gossop, M., et al. (1996). A Review of the Legislation, Regulation and Delivery of Methadone in 12 Member States in the European Union. Brussels: The European Commission.

Data for 2003 and 2005 were provided by NFPs through Standard Table 21 'Treatment availability' submitted in 2004 and 2006. The national data are available in Table HSR-7. Value for 2003 is underestimated as data for Scotland and N. Ireland not available.

Page last updated: Thursday, 15 November 2007